Cannon Financial Strategists’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Cannon Financial Strategists's AMGN Position: Q1 2026 in Review
Cannon Financial Strategists reduced its Amgen (AMGN) stake by 39% in Q1 2026, selling an estimated $284K and leaving 1,226 shares worth $431K. The position accounts for 0.06% of the portfolio, ranked #72.
Cannon Financial Strategists first reported a position in AMGN in Q3 2023 and has held it in 11 quarters since. The position peaked at $662K in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Cannon Financial Strategists held 1,226 shares of Amgen worth $431K as of Q1 2026.
- Cannon Financial Strategists sold 796 Amgen shares in Q1 2026, an estimated $284K.
- Amgen made up 0.06% of Cannon Financial Strategists's portfolio in Q1 2026, its #72 holding.
- Cannon Financial Strategists first reported a position in Amgen in Q3 2023 and has held it in 11 quarters since.
- Cannon Financial Strategists's Amgen position peaked at $662K in Q4 2025.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Cannon Financial Strategists's 13F filing for Q1 2026, filed 12 May 2026.